Effects of Propofol vs. Sevoflurane Anesthesia on Ovarian Cancer Outcomes
Impact of Propofol-Based Total Intravenous Anesthesia Versus Anesthesia With Sevoflurane on Long-term Outcomes With Patients Undergoing Elective Surgery for Primary Ovarian Cancer
This study tests whether using Propofol or Sevoflurane anesthesia during surgery for ovarian cancer affects recovery and survival for patients.
Quick facts
| Phase | Phase 4 |
|---|---|
| Study type | Interventional |
| Enrollment | 416 (estimated) |
| Ages | 20 Years to 80 Years |
| Sex | Female |
| Sponsor | Kaohsiung Medical University Chung-Ho Memorial Hospital Academic / other |
| Drugs / interventions | chemotherapy, radiation |
| Locations | 1 site (Kaohsiung City) |
| Trial ID | NCT05606692 on ClinicalTrials.gov |
What this trial studies
This clinical trial investigates the effects of two different anesthetic agents, Propofol and Sevoflurane, on patients undergoing surgery for primary ovarian cancer. Participants are randomly assigned to receive either Propofol or Sevoflurane during their elective craniotomy, with careful monitoring of various clinical parameters such as vital signs, postoperative complications, and overall survival rates. The study aims to assess how the choice of anesthesia influences patient outcomes, including recovery and survival over a three-year period.
Who should consider this trial
Good fit: Ideal candidates are patients aged 20 to 80 years with ASA class I-III undergoing elective surgery for primary ovarian tumors.
Not a fit: Patients with severe mental disorders, poor liver function, or those undergoing non-primary ovarian cancer surgeries may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could provide insights into optimizing anesthesia for improved survival and recovery in ovarian cancer patients.
How similar studies have performed: Other studies have shown varying results regarding the impact of anesthetic choice on cancer outcomes, making this investigation both relevant and necessary.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Twenty to eighty-year-old. 2. ASA class I-III. 3. Patients undergoing elective craniotomy for primary ovarian tumors under general anesthesia. Exclusion Criteria: 1. Severe mental disorder 2. Poor liver function 3. Pregnant or lactating women 4. Morbid obesity 5. Have a history of allergy to any drug used in this study 6. Non-primary ovarian cancer surgery 7. Undergoing ovarian cancer pathological section surgery 8. Patients with incomplete medical records 9. Combined with other surgeries, emergency surgeries 10. Concomitant patients with other non-ovarian cancer therapy 11. Patients receiving palliative treatment after ovarian cancer surgery 12. During the maintenance period of anesthesia, propofol or sevoflurane should not be used as anesthetic drugs 13. Intraoperative combined use of multiple anesthetics (such as ketamine, dexmedetomidine, other inhalation anesthetics) 14. Those diagnosed with benign tumors before and after surgery 15. Patients with metastases to the ovary
Where this trial is running
Kaohsiung City
- Kaohsiung Medical University Chung-Ho Memorial Hospital — Kaohsiung City, Taiwan (Recruiting)
Study contacts
- Principal investigator: Zhi-Fu Wu — Kaohsiung Medical University
- Study coordinator: Zhi-Fu Wu, MD
- Email: aneswu@gmail.com
- Phone: 07-3121101
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.